DEA schedule
Is memantine a controlled substance?
Federal schedule for memantine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Memantine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and memantine is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted memantine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 120 prescription listings from 39 labelers, none with a DEA schedule |
| DEA controlled substances list | memantine is not on the list |
Memantine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 71610-011 | memantine hydrochloride | tablet | 10 mg/1 | Aphena Pharma Solutions - Tennessee, LLC | None |
| 60505-6162 | MEMANTINE | solution | 2 mg/mL | Apotex Corp. | None |
| 0615-8319 | Memantine | tablet | 10 mg/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
| 60687-184 | Memantine | tablet | 10 mg/1 | American Health Packaging | None |
| 62135-896 | memantine | tablet | 10 mg/1 | Chartwell RX, LLC | None |
| 72603-119 | Memantine | tablet | 10 mg/1 | NorthStar RxLLC | None |
| 0615-8192 | Memantine | tablet | 5 mg/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
| 60687-173 | Memantine | tablet | 5 mg/1 | American Health Packaging | None |
| 62135-895 | memantine | tablet | 5 mg/1 | Chartwell RX, LLC | None |
| 72603-118 | Memantine | tablet | 5 mg/1 | NorthStar RxLLC | None |
| 72189-538 | Memantine HCL | tablet | 10 mg/1 | Direct_Rx | None |
| 16571-853 | Memantine Hydrochloride | capsule, extended release | 14 mg/1 | Rising Pharma Holdings, Inc. | None |
| 33342-220 | Memantine hydrochloride | capsule, extended release | 14 mg/1 | Macleods Pharmaceuticals Limited | None |
| 59651-405 | MEMANTINE HYDROCHLORIDE | capsule, extended release | 14 mg/1 | Aurobindo Pharma Limited | None |
| 65162-783 | Memantine Hydrochloride | capsule, extended release | 14 mg/1 | Amneal Pharmaceuticals LLC | None |
| 68180-247 | memantine hydrochloride | capsule, extended release | 14 mg/1 | Lupin Pharmaceuticals, Inc. | None |
| 68382-547 | Memantine hydrochloride | capsule, extended release | 14 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 69680-162 | Memantine Hydrochloride | capsule, extended release | 14 mg/1 | Vitruvias Therapeutics, Inc. | None |
| 70436-055 | Memantine Hydrochloride | capsule, extended release | 14 mg/1 | Slate Run Pharmaceuticals, LLC | None |
| 70771-1322 | Memantine hydrochloride | capsule, extended release | 14 mg/1 | Zydus Lifesciences Limited | None |
| 16571-854 | Memantine Hydrochloride | capsule, extended release | 21 mg/1 | Rising Pharma Holdings, Inc. | None |
| 33342-221 | Memantine hydrochloride | capsule, extended release | 21 mg/1 | Macleods Pharmaceuticals Limited | None |
| 59651-406 | MEMANTINE HYDROCHLORIDE | capsule, extended release | 21 mg/1 | Aurobindo Pharma Limited | None |
| 65162-784 | Memantine Hydrochloride | capsule, extended release | 21 mg/1 | Amneal Pharmaceuticals LLC | None |
| 68180-248 | memantine hydrochloride | capsule, extended release | 21 mg/1 | Lupin Pharmaceuticals, Inc. | None |
| 68382-548 | Memantine hydrochloride | capsule, extended release | 21 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 69680-163 | Memantine Hydrochloride | capsule, extended release | 21 mg/1 | Vitruvias Therapeutics, Inc. | None |
| 70436-056 | Memantine Hydrochloride | capsule, extended release | 21 mg/1 | Slate Run Pharmaceuticals, LLC | None |
| 70771-1323 | Memantine hydrochloride | capsule, extended release | 21 mg/1 | Zydus Lifesciences Limited | None |
| 0615-8662 | MEMANTINE HYDROCHLORIDE | capsule, extended release | 28 mg/1 | NCS HealthCare of KY, LLC dba Vangard Labs | None |
| 16571-855 | Memantine Hydrochloride | capsule, extended release | 28 mg/1 | Rising Pharma Holdings, Inc. | None |
| 33342-222 | Memantine hydrochloride | capsule, extended release | 28 mg/1 | Macleods Pharmaceuticals Limited | None |
| 59651-407 | MEMANTINE HYDROCHLORIDE | capsule, extended release | 28 mg/1 | Aurobindo Pharma Limited | None |
| 65162-785 | Memantine Hydrochloride | capsule, extended release | 28 mg/1 | Amneal Pharmaceuticals LLC | None |
| 68180-249 | memantine hydrochloride | capsule, extended release | 28 mg/1 | Lupin Pharmaceuticals, Inc. | None |
| 68382-549 | Memantine hydrochloride | capsule, extended release | 28 mg/1 | Zydus Pharmaceuticals USA Inc. | None |
| 69680-164 | Memantine Hydrochloride | capsule, extended release | 28 mg/1 | Vitruvias Therapeutics, Inc. | None |
| 70436-057 | Memantine Hydrochloride | capsule, extended release | 28 mg/1 | Slate Run Pharmaceuticals, LLC | None |
| 70771-1324 | Memantine hydrochloride | capsule, extended release | 28 mg/1 | Zydus Lifesciences Limited | None |
| 0904-6734 | memantine hydrochloride | capsule, extended release | 7 mg/1 | Major Pharmaceuticals | None |
Showing 40 of 120 listings.
Questions
Is memantine a controlled substance?
No. Memantine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and memantine is not on the DEA controlled substances list.
Is memantine a narcotic?
No. Memantine is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is N-methyl-D-aspartate Receptor Antagonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.